Complete hydatidiform mole (CHM) is a premalignant proliferative disease of the placenta characterized by misexpression of imprinted gene products, most notably p57. The majority of CHM exhibit immunohistochemical absence of p57 protein in villous mesenchyme (VM) and cytotrophoblast (CT) and are thus p57 VM/CT concordant. However, some gestations show loss of p57 in only VM or CT, either in all chorionic villi or a subset thereof (VM/CT discordant). Here, we present a rare case of a p57 VM/CT-discordant CHM with diffuse retention of p57 expression in VM but complete absence in CT. Histologically, the case exhibited typical features of CHM including trophoblast hyperplasia and severe nuclear atypia, but was unusual in the presence of gestational membranes identified ultrasonographically and histologically. Ploidy determination by FISH and genotyping by short tandem repeat analyses showed that this was a diploid gestation with variable allelic ratios and with an androgenetic lineage, similar to previously reported p57 VM/CT-discordant cases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663530PMC
http://dx.doi.org/10.1097/PGP.0000000000000773DOI Listing

Publication Analysis

Top Keywords

p57 expression
12
p57
9
complete hydatidiform
8
hydatidiform mole
8
villous mesenchyme
8
p57 vm/ct-discordant
8
rare complete
4
mole p57
4
expression villous
4
mesenchyme case
4

Similar Publications

The different spatiotemporal distribution of progenitor and neurogenic capacities permits that brain regions engage asynchronously in neurogenesis. In the hindbrain, rhombomere progenitor cells contribute to neurons during the first neurogenic phase, whereas boundary cells participate later. To analyze what maintains boundary cells as non-neurogenic progenitors, we addressed the role of Her9, a zebrafish Hes1-related protein.

View Article and Find Full Text PDF
Article Synopsis
  • PDGF/PDGFRB genes significantly influence coronary atherosclerosis, and a study found genetic variations in these pathways linked to coronary artery disease (CAD).
  • The research involved 3139 CAD patients and 3270 controls, examining 13 SNPs to create a weighted genetic risk score (wGRS) associated with CAD risk.
  • Findings showed that higher wGRS correlated with increased CAD risk, and lower mRNA expressions of related genes in patients may serve as potential blood-based biomarkers for CAD.
View Article and Find Full Text PDF

Objective: We report the first documented case of concurrent ectopic complete hydatidiform mole (CHM) and high-grade serous carcinoma (HGSC) of the fallopian tube, associated with unique histologic features and mutations in the HGSC.

Case Report: The patient presented with pelvic pain and vaginal bleeding. Laboratory examination revealed a positive urine pregnancy test and high serum beta-human chorionic gonadotropin (β-hCG).

View Article and Find Full Text PDF

Identification and characterization of an enhancer element regulating expression of Cdkn1c (p57 gene).

Genes Cells

December 2024

Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

The mammalian p57 protein is a member of the CIP/KIP family of cyclin-dependent kinase inhibitors and plays an essential role in the development of multiple tissues during embryogenesis as well as in the maintenance of tissue stem cells in adults. Although several transcription factors have been implicated in regulating the p57 gene, cis-elements such as enhancers that regulate its expression have remained ill-defined. Here we identify a candidate enhancer for the mouse p57 gene (Cdkn1c) within an intron of the Kcnq1 locus by 4C-seq analysis in mouse embryonic stem cells (mESCs).

View Article and Find Full Text PDF
Article Synopsis
  • Polycystic ovary syndrome (PCOS) is a common health issue for women that affects how their bodies work, and researchers are looking for better ways to understand and treat it.
  • Scientists studied how two important proteins, CDKN1C and YY1, behave in cells related to PCOS and found that when CDKN1C is less active, cells grow more and die less.
  • The study suggests that controlling the activity of CDKN1C, influenced by YY1, could be a new way to help treat PCOS.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!